Eric Austin Email & Phone Number
VP, Toxicology and ADME @ Gilgamesh Pharmaceuticals
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Eric Austin Location
- Boston, MA, US
Eric Austin Work
- VP, Toxicology and ADME @ (November 2025 - Present)
- VP, Toxicology and ADME @ (March 2022 - Present)
- Head of Integrated Pharmacology Research @ Gilgamesh Pharmaceutical (October 2020 - March 2022)
- Senior Director, Head of Toxicology @ Kintai Therapeutics (November 2019 - June 2020)
- Global Early Development Lead @ (January 2015 - November 2019)
- Associate Director and Non-Clinical Safety Program Manager @ (January 2014 - November 2019)
- Owner @ Austin Preclinical Consulting (September 2010 - December 2015)
- Senior Manager, Toxicology @ (January 2012 - December 2013)
- Senior Toxicology Consultant @ (March 2007 - September 2010)
- Senior Staff Scientist and Toxicolgist @ ICOS Corporation (May 2002 - February 2007)
- Study Director @ Covance Laboratories (June 1998 - May 2002)
- Staff Scientist @ AMUR Pharmaceuticals, Inc. (July 1996 - June 1998)
Eric Austin Education
- Washington State University
Ph.D. (Pharmacology and Toxicology)
1990-1996 - UCLA
BS (Microbiology)
1983-1987
Eric Austin Skills
- Assay Development
- Biologics
- Biologics Drug Development
- Biopharmaceuticals
- Biotechnology
- CRO
- Cancer
- Cell Culture
- Chemistry
- Clinical Development
- Clinical Research
- Clinical Trials
- Conceptual Modeling
- Drug Development
- Drug Discovery
- Efficacy
- FDA
- GCP
- GLP
- GLP Toxicology
- Good Laboratory Practice (GLP)
- IND
- Immunology
- In Vitro
- In Vivo
- Intellectual property evaluation
- Laboratory
- Life Sciences
- Lifesciences
- Molecular Biology
- Oncology
- Pharmaceutical Industry
- Pharmacokinetics
- Pharmacologic Animal Efficacy Models
- Preclinical Development
- Preclinical Project Management
- Protein Chemistry
- Regulatory Affairs
- Regulatory Submissions
- Small Molecule Drug Development
- Small Molecules
- Technology Transfer
- Toxicology
- Vaccines
- Development
- Early Development
- Toxicologist
Eric Austin Summary
- Eric Austin, based in Boston, MA, US, is currently a VP, Toxicology and ADME at Gilgamesh Pharma. Eric Austin brings experience from previous roles at Gilgamesh Pharma, Gilgamesh Pharmaceutical, Kintai Therapeutics and EMD Serono, Inc.. Eric Austin holds a 1990 - 1996 Ph.D. in Pharmacology and Toxicology @ Washington State University. With a robust skill set that includes Assay Development, Biologics, Biologics Drug Development, Biopharmaceuticals, Biotechnology and more. Eric Austin has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Eric Austin?
Find contact details for 700 million professionals.
Others Named Eric Austin
Eric Austin
Vice President, Marketing and Media Innovation
Cincinnati, OH, US
Eric Austin
Senior Principal Electrical Engineer
Boston, MA, US
Eric Austin
Woodbury Market President
Saint Paul, MN, US
Eric Austin
Commanding General
Quantico, VA, US
Eric Austin
Inside Sales Specialist
Seymour, IN, US
Eric Austin
Director, Walmart Energy - Regulatory - FERC and RTO
Bentonville, AR, US
Eric Austin
Group Director Security and Systems
Tallinn, EE
Eric Austin
Managing Partner
New York, United States
Eric Austin
Chief Financial Officer
Aiea, HI, US
Top Gilgamesh Pharmaceuticals Employees
Kimberly Chambert
Sr. Director, Program Management
Milton, MA, US
Jason Winters
Head of Clinical Operations
Hightstown, NJ, US
Jeff Moehlenkamp
VP, Head of Nonclinical Development
Newburgh, IN, US
Yoni Falkson
Chief Operating Officer
Chapel Hill, NC, US
Eric Austin
VP, Toxicology and ADME
Boston, MA, US
Bridget Walton
Vice President, Global Regulatory Affairs
United States
Matthew Horsman
Senior Controller
Newton, MA, US
Michael Cunningham
Co-founder, Scientist
New York, NY, US
Zoë Hughes
EVP, Biology and Translational Medicine
United States
Dino Dvorak
Senior Director, Translational Biomarkers
New York, NY, US
Thomas Murphy
Head of R and D Operations
New York, NY, US
Peter Germano
Executive Director, DMPK
Boston, MA, US
Yana Lazarova-Weng
Intern
California, United States
Adam Klein
Senior Scientist
Burbank, CA, US
John Klecker
Senior Scientist DMPK and Toxicology
Saint Paul, MN, US
Bruce Melancon
Senior Principal Scientist
Nashville, TN, US
Gerard Marek
Chief Medical Officer
Vernon Hills, IL, US
James Henkelis
Director of Drug Substance Development
Princeton, NJ, US
Nina Dedic
Senior Director, Pharmacology
Boston, MA, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co